Birgit Reitmaier, MBAExecutive Director, Head of Access to Innovation in APAC, Biopharma | Global Business Development and Alliance Management at Merck
Agenda Sessions
Clinical development, commercialization and partnering in China: How China has fundamentally altered the global clinical development landscape
, 16:00View Session